quinapril 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
angiotensin-converting enzyme inhibitors 2340 85441-61-8

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • quinapril
  • ectren
  • koretic
  • quinapril hydrochloride
  • quinapril HCl
A tetrahydroisoquinoline derivative and ANGIOTENSIN CONVERTING ENZYME inhibitor that is used in the treatment of HYPERTENSION and HEART FAILURE.
  • Molecular weight: 438.52
  • Formula: C25H30N2O5
  • CLOGP: 1.74
  • LIPINSKI: 0
  • HAC: 7
  • HDO: 2
  • TPSA: 95.94
  • ALOGS: -4.71
  • ROTB: 10
  • Status: OFP
    • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

DoseUnitRoute
15 mg O
15 mg P

ADMET properties:

PropertyValueReference
BDDCS (Biopharmaceutical Drug Disposition Classification System) 1 Bocci G, Oprea TI, Benet LZ
S (Water solubility) 0.00 mg/mL Benet LZ, Broccatelli F, Oprea TI
EoM (Fraction excreted unchanged in urine) 3.10 % Benet LZ, Broccatelli F, Oprea TI
MRTD (Maximum Recommended Therapeutic Daily Dose) 2.61 µM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD
BA (Bioavailability) 60 % Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H

Approvals:

DateAgencyCompanyOrphan
Nov. 19, 1991 FDA PFIZER PHARMS

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Sedation complication 1059.87 16.07 307 16470 13515 63458730
Orthostatic hypotension 1029.54 16.07 379 16398 35781 63436464
Creatinine renal clearance decreased 1026.90 16.07 311 16466 15997 63456248
Sedation 952.85 16.07 365 16412 38444 63433801
Cognitive disorder 876.65 16.07 381 16396 55434 63416811
Blood calcium decreased 871.50 16.07 309 16468 26142 63446103
Balance disorder 746.47 16.07 388 16389 84034 63388211
Depressed level of consciousness 655.81 16.07 322 16455 61756 63410489
Constipation 448.83 16.07 412 16365 224531 63247714
Mobility decreased 428.14 16.07 310 16467 120849 63351396
Fall 398.30 16.07 502 16275 391832 63080413
Hypotension 380.23 16.07 411 16366 272193 63200052
Toxicity to various agents 271.90 16.07 330 16447 246920 63225325
Cardiac failure congestive 102.18 16.07 124 16653 92309 63379936
Hypertensive emergency 97.63 16.07 31 16746 1851 63470394
Heart sounds 89.13 16.07 25 16752 971 63471274
Prolonged expiration 86.76 16.07 25 16752 1071 63471174
Myocardial infarction 82.36 16.07 116 16661 99777 63372468
Pain 80.73 16.07 397 16380 740231 62732014
Multiple drug therapy 77.60 16.07 31 16746 3615 63468630
Coronary artery disease 67.46 16.07 61 16716 32316 63439929
Cerebrovascular accident 63.11 16.07 107 16670 107917 63364328
Drug ineffective 62.94 16.07 113 16664 1044652 62427593
Depressive symptom 57.72 16.07 26 16751 4076 63468169
Off label use 56.69 16.07 57 16720 674405 62797840
Respiration abnormal 46.69 16.07 26 16751 6391 63465854
Angina pectoris 46.31 16.07 48 16729 30030 63442215
Appetite disorder 43.51 16.07 26 16751 7295 63464950
Systemic lupus erythematosus 38.27 16.07 5 16772 208913 63263332
Rash 36.99 16.07 57 16720 560814 62911431
Therapeutic product effect decreased 34.50 16.07 5 16772 193182 63279063
Sleep disorder due to a general medical condition 33.65 16.07 27 16750 12161 63460084
Synovitis 33 16.07 5 16772 186913 63285332
Flank pain 32.38 16.07 30 16747 16380 63455865
Rales 30.61 16.07 26 16751 12671 63459574
Arthropathy 30.40 16.07 12 16765 234780 63237465
Alopecia 30.05 16.07 27 16750 337509 63134736
Wound 29.68 16.07 4 16773 163259 63308986
Discomfort 28.38 16.07 5 16772 167369 63304876
Exposure during pregnancy 27.83 16.07 4 16773 155543 63316702
Drug intolerance 27.10 16.07 25 16752 308636 63163609
Glossodynia 25.10 16.07 8 16769 178868 63293377
General physical health deterioration 24.93 16.07 11 16766 201391 63270854
Product use issue 24.37 16.07 14 16763 220506 63251739
Neutropenia 24.25 16.07 8 16769 174997 63297248
Injury 23.96 16.07 57 16720 73190 63399055
Hepatic enzyme increased 23.59 16.07 12 16765 202316 63269929
Infection 22.02 16.07 17 16760 229156 63243089
Infusion related reaction 21.40 16.07 20 16757 245501 63226744
Joint swelling 20.89 16.07 34 16743 327632 63144613
Product complaint 20.72 16.07 21 16756 12788 63459457
Hypersensitivity 19.97 16.07 29 16748 292656 63179589
Completed suicide 19.59 16.07 7 16770 145666 63326579
Blood glucose increased 19.09 16.07 57 16720 83699 63388546
Arthralgia 18.87 16.07 82 16695 569628 62902617
Fear 18.79 16.07 22 16755 15744 63456501
Fatigue 18.67 16.07 148 16629 887880 62584365
Peripheral swelling 18.48 16.07 26 16751 265916 63206329
Acute myocardial infarction 17.66 16.07 31 16746 32093 63440152
Weight increased 17.63 16.07 26 16751 260766 63211479
Angioedema 17.53 16.07 39 16738 47926 63424319
Chest pain 17.40 16.07 107 16670 215852 63256393
Abdominal discomfort 17.18 16.07 37 16740 320848 63151397
Febrile neutropenia 17.15 16.07 5 16772 118444 63353801
Coronary artery occlusion 16.21 16.07 15 16762 8176 63464069
Pancytopenia 16.20 16.07 3 16774 96930 63375315

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Myocardial infarction 124.30 14.59 157 9174 120928 34826672
Coronary artery disease 118.14 14.59 100 9231 48205 34899395
Cardiac failure congestive 101.71 14.59 118 9213 83152 34864448
Blood mercury abnormal 101.26 14.59 21 9310 213 34947387
5-hydroxyindolacetic acid in urine increased 99.30 14.59 21 9310 236 34947364
Low density lipoprotein decreased 72.45 14.59 22 9309 1121 34946479
Expired product administered 62.61 14.59 26 9305 3315 34944285
Head titubation 58.89 14.59 15 9316 396 34947204
Hepatic neoplasm 56.91 14.59 21 9310 1956 34945644
Blood glucose increased 55.21 14.59 78 9253 66640 34880960
Acute myocardial infarction 49.24 14.59 66 9265 53653 34893947
Cerebrovascular accident 48.98 14.59 84 9247 84727 34862873
Arteriosclerosis coronary artery 46.04 14.59 33 9298 12452 34935148
Glycosylated haemoglobin increased 44.14 14.59 31 9300 11329 34936271
Off label use 42.83 14.59 30 9301 419494 34528106
Cogwheel rigidity 41.28 14.59 15 9316 1337 34946263
Hypertensive emergency 41.18 14.59 14 9317 1026 34946574
Neoplasm 39.17 14.59 22 9309 5445 34942155
Sedation complication 30.52 14.59 13 9318 1764 34945836
Injury 29.78 14.59 32 9299 20655 34926945
Coronary artery occlusion 27.37 14.59 23 9308 10939 34936661
Neutropenia 26.30 14.59 5 9326 156773 34790827
Angioedema 25.57 14.59 40 9291 37334 34910266
Cardiac disorder 25.23 14.59 43 9288 43083 34904517
General physical health deterioration 23.99 14.59 3 9328 128266 34819334
Myocardial ischaemia 23.44 14.59 26 9305 17382 34930218
Pseudohyponatraemia 22.69 14.59 5 9326 69 34947531
Syncope 21.22 14.59 63 9268 91388 34856212
Blood potassium decreased 21.15 14.59 25 9306 17890 34929710
Hypoaesthesia 21.09 14.59 49 9282 61395 34886205
Chest pain 21.09 14.59 78 9253 126684 34820916
Bronchomalacia 19.70 14.59 5 9326 130 34947470
Arrhythmia 18.74 14.59 34 9297 35774 34911826
Extrapyramidal disorder 18.67 14.59 20 9311 12860 34934740
Drug hypersensitivity 18.23 14.59 55 9276 80474 34867126
Fibrous histiocytoma 18.22 14.59 5 9326 177 34947423
Blood follicle stimulating hormone increased 18.19 14.59 5 9326 178 34947422
Paralysis 17.80 14.59 14 9317 6068 34941532
Coronary arterial stent insertion 17.76 14.59 12 9319 4117 34943483
Anticholinergic syndrome 17.64 14.59 8 9323 1261 34946339
Urticaria 17.44 14.59 46 9285 62331 34885269
Haematocrit decreased 17.38 14.59 31 9300 32185 34915415
Drug abuse 16.95 14.59 3 9328 99093 34848507
Angina unstable 16.72 14.59 18 9313 11635 34935965
Arteriosclerosis 16.33 14.59 18 9313 11950 34935650
Nephropathy 15.99 14.59 13 9318 5904 34941696
Rhabdomyolysis 15.84 14.59 47 9284 68116 34879484
Pyrexia 15.52 14.59 42 9289 332971 34614629
Angina pectoris 15.43 14.59 29 9302 31334 34916266
Cardiopulmonary failure 15.38 14.59 11 9320 4134 34943466
Ischaemic cardiomyopathy 15.12 14.59 13 9318 6376 34941224
Febrile neutropenia 14.96 14.59 9 9322 136840 34810760
Blood pressure systolic increased 14.91 14.59 24 9307 22928 34924672

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Sedation complication 1100.37 13.97 330 22144 15339 79706575
Creatinine renal clearance decreased 996.45 13.97 320 22154 18682 79703232
Orthostatic hypotension 885.10 13.97 392 22082 55772 79666142
Sedation 849.33 13.97 372 22102 51523 79670391
Blood calcium decreased 845.82 13.97 323 22151 31496 79690418
Cognitive disorder 803.01 13.97 392 22082 69534 79652380
Balance disorder 691.31 13.97 398 22076 98459 79623455
Depressed level of consciousness 522.46 13.97 330 22144 96322 79625592
Mobility decreased 468.21 13.97 337 22137 121838 79600076
Constipation 356.68 13.97 418 22056 282632 79439282
Fall 331.77 13.97 534 21940 487095 79234819
Hypotension 273.31 13.97 463 22011 439854 79282060
Cardiac failure congestive 191.76 13.97 218 22256 142184 79579730
Myocardial infarction 186.43 13.97 244 22230 183885 79538029
Coronary artery disease 181.06 13.97 149 22325 65325 79656589
Toxicity to various agents 153.66 13.97 355 22119 421185 79300729
Hypertensive emergency 129.97 13.97 43 22431 2742 79719172
Pain 119.26 13.97 451 22023 703351 79018563
Cerebrovascular accident 103.44 13.97 169 22305 155123 79566791
Blood mercury abnormal 100.11 13.97 21 22453 213 79721701
5-hydroxyindolacetic acid in urine increased 97.98 13.97 21 22453 238 79721676
Off label use 95.77 13.97 70 22404 907145 78814769
Heart sounds 83.78 13.97 24 22450 942 79720972
Prolonged expiration 77.28 13.97 24 22450 1247 79720667
Multiple drug therapy 72.31 13.97 31 22443 4047 79717867
Low density lipoprotein decreased 69.83 13.97 22 22452 1199 79720715
Acute myocardial infarction 64.12 13.97 93 22381 76943 79644971
Drug ineffective 56.40 13.97 140 22334 1080773 78641141
Angina pectoris 54.47 13.97 70 22404 51662 79670252
Arteriosclerosis coronary artery 52.26 13.97 42 22432 17774 79704140
Blood glucose increased 52.15 13.97 106 22368 114869 79607045
Neutropenia 48.22 13.97 11 22463 287699 79434215
Expired product administered 48.08 13.97 28 22446 7023 79714891
Injury 45.78 13.97 80 22394 77416 79644498
Hepatic neoplasm 44.65 13.97 21 22453 3405 79718509
Depressive symptom 42.46 13.97 25 22449 6398 79715516
Respiration abnormal 40.48 13.97 26 22448 7762 79714152
General physical health deterioration 39.69 13.97 14 22460 275224 79446690
Appetite disorder 38.17 13.97 25 22449 7714 79714200
Coronary artery occlusion 34.45 13.97 31 22443 15284 79706630
Angioedema 33.17 13.97 69 22405 75966 79645948
Febrile neutropenia 32.87 13.97 12 22462 230987 79490927
Therapeutic product effect decreased 32.44 13.97 4 22470 163859 79558055
Rash 32.35 13.97 72 22402 578286 79143628
Glycosylated haemoglobin increased 32.01 13.97 33 22441 19227 79702687
Completed suicide 31.38 13.97 15 22459 245752 79476162
Chest pain 30.79 13.97 159 22315 282145 79439769
Product complaint 29.99 13.97 27 22447 13322 79708592
Synovitis 29.06 13.97 4 22470 150730 79571184
Infection 29.00 13.97 16 22458 241696 79480218
Pancytopenia 28.44 13.97 6 22468 165739 79556175
Flank pain 27.70 13.97 31 22443 19813 79702101
Head titubation 26.60 13.97 10 22464 928 79720986
Myocardial ischaemia 26.02 13.97 34 22440 25485 79696429
Neoplasm 25.70 13.97 21 22453 9095 79712819
Sleep disorder due to a general medical condition 24.70 13.97 25 22449 14252 79707662
Arteriosclerosis 24.63 13.97 28 22446 18199 79703715
Ischaemic cardiomyopathy 24.41 13.97 19 22455 7676 79714238
Condition aggravated 22.92 13.97 69 22405 501055 79220859
Wound 22.59 13.97 3 22471 116176 79605738
Thrombocytopenia 22.43 13.97 25 22449 265234 79456680
Product use issue 22.26 13.97 16 22458 209806 79512108
Drug intolerance 22.21 13.97 25 22449 264094 79457820
Angina unstable 21.68 13.97 25 22449 16502 79705412
Pyrexia 21.13 13.97 109 22365 678600 79043314
Hyperlipidaemia 20.97 13.97 31 22443 26062 79695852
Stress 20.51 13.97 59 22415 79553 79642361
Drug hypersensitivity 20.30 13.97 149 22325 298767 79423147
Pericarditis 19.55 13.97 3 22471 104233 79617681
Rales 19.39 13.97 26 22448 19975 79701939
Pseudohyponatraemia 19.36 13.97 5 22469 132 79721782
Alopecia 19.34 13.97 22 22452 231333 79490581
Exposure during pregnancy 18.76 13.97 3 22471 101129 79620785
Transient ischaemic attack 18.66 13.97 44 22430 52651 79669263
Intentional product use issue 18.34 13.97 10 22464 152102 79569812
Carotid artery stenosis 18.28 13.97 17 22457 8741 79713173
Infusion related reaction 18.07 13.97 23 22451 230214 79491700
Intentional overdose 17.84 13.97 4 22470 105956 79615958
Fear 17.49 13.97 26 22448 21960 79699954
Fatigue 17.38 13.97 173 22301 929554 78792360
Product dose omission issue 17.17 13.97 27 22447 247510 79474404
Emotional distress 17.11 13.97 36 22438 39933 79681981
Arthropathy 16.91 13.97 15 22459 177096 79544818
Blood potassium decreased 16.65 13.97 39 22435 46473 79675441
Bronchomalacia 15.88 13.97 5 22469 272 79721642
Pneumonia 15.85 13.97 115 22359 660131 79061783
Discomfort 15.52 13.97 8 22466 125609 79596305
Cardiac disorder 15.29 13.97 47 22427 65710 79656204
Cogwheel rigidity 15.29 13.97 10 22464 3078 79718836
Essential hypertension 15.11 13.97 13 22461 6040 79715874
Decreased appetite 15.03 13.97 48 22426 342370 79379544
Leukopenia 15.03 13.97 7 22467 116506 79605408
Blood follicle stimulating hormone increased 14.84 13.97 5 22469 337 79721577
Peripheral swelling 14.68 13.97 34 22440 269583 79452331
Hepatic enzyme increased 14.58 13.97 18 22456 182592 79539322
Joint swelling 14.47 13.97 38 22436 288608 79433306
COVID-19 14.29 13.97 14 22460 157660 79564254

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC C09AA06 CARDIOVASCULAR SYSTEM
AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
ACE INHIBITORS, PLAIN
ACE inhibitors, plain
ATC C09BA06 CARDIOVASCULAR SYSTEM
AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
ACE INHIBITORS, COMBINATIONS
ACE inhibitors and diuretics
FDA MoA N0000000181 Angiotensin-converting Enzyme Inhibitors
FDA EPC N0000175562 Angiotensin Converting Enzyme Inhibitor
MeSH PA D000806 Angiotensin-Converting Enzyme Inhibitors
MeSH PA D000959 Antihypertensive Agents
MeSH PA D002317 Cardiovascular Agents
MeSH PA D004791 Enzyme Inhibitors
MeSH PA D011480 Protease Inhibitors
CHEBI has role CHEBI:35457 ACE inhibitor
CHEBI has role CHEBI:35674 antihypertensive drugs
CHEBI has role CHEBI:50266 Prodrugs
CHEBI has role CHEBI:35620 vasodilator agents

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Hypertensive disorder indication 38341003 DOID:10763
Chronic heart failure indication 48447003
Atrial fibrillation off-label use 49436004 DOID:0060224
Diabetic renal disease off-label use 127013003
Acute scleroderma renal crisis off-label use 236503001
Diastolic heart failure off-label use 418304008 DOID:9775
Nondiabetic Proteinuric Nephropathy off-label use
Anuria contraindication 2472002 DOID:2983
Hypercholesterolemia contraindication 13644009
Hyperkalemia contraindication 14140009
Secondary angle-closure glaucoma contraindication 21571006
Hypovolemia contraindication 28560003
Acute cerebrovascular insufficiency contraindication 29322000
Dehydration contraindication 34095006
Hyperuricemia contraindication 35885006 DOID:1920
Immunosuppression contraindication 38013005
Angioedema contraindication 41291007 DOID:1558
Hypokalemia contraindication 43339004
Low blood pressure contraindication 45007003
Systemic lupus erythematosus contraindication 55464009 DOID:9074
Sympathectomy contraindication 57071006
Hypercalcemia contraindication 66931009 DOID:12678
Hyperparathyroidism contraindication 66999008 DOID:13543
Hypochloremic alkalosis contraindication 70134007
Hepatic coma contraindication 72836002 DOID:12550
Diabetes mellitus contraindication 73211009 DOID:9351
Hereditary angioneurotic edema contraindication 82966003 DOID:14735
Hyponatremia contraindication 89627008
Gout contraindication 90560007 DOID:13189
Kidney disease contraindication 90708001 DOID:557
Disorder of connective tissue contraindication 105969002 DOID:65
Hypomagnesemia contraindication 190855004
Acute pancreatitis contraindication 197456007 DOID:2913
Disease of liver contraindication 235856003 DOID:409
Neonatal hyperbilirubinemia contraindication 281610001
Pregnancy, function contraindication 289908002
Renal artery stenosis contraindication 302233006
Neutropenic disorder contraindication 303011007 DOID:1227
Bone marrow depression contraindication 307762000
Myocardial ischemia contraindication 414795007 DOID:3393
Azotemia contraindication 445009001
Hemodialysis with High-Flux Membrane contraindication




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 2.96 acidic
pKa2 5.72 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])		Mechanism
action		Bioact sourceMoA source
Angiotensin-converting enzyme Enzyme INHIBITOR IC50 8.08 CHEMBL CHEMBL
Angiotensin-converting enzyme Enzyme IC50 5.40 DRUG MATRIX

External reference:

IDSource
4020549 VUID
N0000148256 NUI
D00459 KEGG_DRUG
82586-55-8 SECONDARY_CAS_RN
4020379 VANDF
4020549 VANDF
C0072857 UMLSCUI
CHEBI:8713 CHEBI
CHEBI:140296 CHEBI
CHEMBL1592 ChEMBL_ID
CHEMBL1201011 ChEMBL_ID
D000077583 MESH_DESCRIPTOR_UI
DB00881 DRUGBANK_ID
6350 IUPHAR_LIGAND_ID
C054501 MESH_SUPPLEMENTAL_RECORD_UI
5780 INN_ID
RJ84Y44811 UNII
54892 PUBCHEM_CID
DB14217 DRUGBANK_ID
1546359 RXNORM
5401 MMSL
63990 MMSL
d00365 MMSL
003612 NDDF
003613 NDDF
108578004 SNOMEDCT_US
386874003 SNOMEDCT_US
386875002 SNOMEDCT_US
C0072858 UMLSCUI
CHEMBL1733 ChEMBL_ID
6356 INN_ID
82768-85-2 SECONDARY_CAS_RN
107994 PUBCHEM_CID
6352 IUPHAR_LIGAND_ID
34SSX5LDE5 UNII

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
ACCURETIC HUMAN PRESCRIPTION DRUG LABEL 2 0071-0220 TABLET, FILM COATED 20 mg ORAL NDA 22 sections
ACCURETIC HUMAN PRESCRIPTION DRUG LABEL 2 0071-0222 TABLET, FILM COATED 10 mg ORAL NDA 22 sections
ACCURETIC HUMAN PRESCRIPTION DRUG LABEL 2 0071-0223 TABLET, FILM COATED 20 mg ORAL NDA 22 sections
ACCURETIC HUMAN PRESCRIPTION DRUG LABEL 2 0071-0223 TABLET, FILM COATED 20 mg ORAL NDA 22 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-0527 TABLET, FILM COATED 5 mg ORAL NDA 25 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-0527 TABLET, FILM COATED 5 mg ORAL NDA 25 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-0527 TABLET, FILM COATED 5 mg ORAL NDA 25 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-0530 TABLET, FILM COATED 10 mg ORAL NDA 25 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-0530 TABLET, FILM COATED 10 mg ORAL NDA 25 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-0530 TABLET, FILM COATED 10 mg ORAL NDA 25 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-0532 TABLET, FILM COATED 20 mg ORAL NDA 25 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-0532 TABLET, FILM COATED 20 mg ORAL NDA 25 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-0532 TABLET, FILM COATED 20 mg ORAL NDA 25 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-0535 TABLET, FILM COATED 40 mg ORAL NDA 25 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-0535 TABLET, FILM COATED 40 mg ORAL NDA 25 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-0535 TABLET, FILM COATED 40 mg ORAL NDA 25 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-1205 TABLET, FILM COATED 5 mg ORAL NDA 25 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-1205 TABLET, FILM COATED 5 mg ORAL NDA 25 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-1205 TABLET, FILM COATED 5 mg ORAL NDA 25 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-1410 TABLET, FILM COATED 10 mg ORAL NDA 25 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-1410 TABLET, FILM COATED 10 mg ORAL NDA 25 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-1410 TABLET, FILM COATED 10 mg ORAL NDA 25 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-1620 TABLET, FILM COATED 20 mg ORAL NDA 25 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-1620 TABLET, FILM COATED 20 mg ORAL NDA 25 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-1620 TABLET, FILM COATED 20 mg ORAL NDA 25 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-1840 TABLET, FILM COATED 40 mg ORAL NDA 25 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-1840 TABLET, FILM COATED 40 mg ORAL NDA 25 sections
Accupril HUMAN PRESCRIPTION DRUG LABEL 1 0071-1840 TABLET, FILM COATED 40 mg ORAL NDA 25 sections
ACCURETIC HUMAN PRESCRIPTION DRUG LABEL 2 0071-3112 TABLET, FILM COATED 10 mg ORAL NDA 22 sections
ACCURETIC HUMAN PRESCRIPTION DRUG LABEL 2 0071-3112 TABLET, FILM COATED 10 mg ORAL NDA 22 sections